Lamotrigine
Cross-source consensus on Lamotrigine from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Dosage & preparation
Preparation
Risks & contraindications
Highlighted claims
- Lamotrigine is titrated slowly to reduce side effects. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)
- The lamotrigine target dose is 200 mg per day over 8 weeks, with a maximum dose of 400 mg per day. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)
- Lamotrigine is administered in the morning because sleep disturbance can occur. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)
- Possible lamotrigine adverse effects include headache, irritability, dizziness, skin symptoms during titration, arthralgia, gastrointestinal symptoms, and sleep disturbance. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)
- Lamotrigine is widely used for bipolar depression and maintenance treatment. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)
- Lamotrigine is considered safe and well tolerated. — Lithium versus lamotrigine in bipolar disorder type II: protocol for a single-blinded, pragmatic, randomised controlled trial (the LiLa-Bipolar RCT)